Skip to main content

In the News

FDA Approvals, In the News

FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma

FDA Moves Quickly to Approve Easy-to-Use Nasal Spray to Treat Opioid Overdose

FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma

FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma

FDA Approves New Pill to Treat Certain Patients with Non—Small-Cell Lung Cancer

FDA Approves Cotellic as Part of Combination Treatment for Advanced Melanoma

FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa

FDA Approves New Injectable Drug to Treat Schizophrenia

Management of the Multiple Sclerosis Category: An Increasing Focus for Payers

Achieving Consensus between Healthcare Providers and Payers

Page 6 of 7
Results 51 - 60 of 63